NeuroBo Pharmaceuticals Inc (NRBO)
4.60
+0.36
(+8.49%)
USD |
NASDAQ |
May 16, 16:00
4.60
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Market Cap: 22.57M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 20.80M |
| May 14, 2024 | 20.16M |
| May 13, 2024 | 19.77M |
| May 10, 2024 | 19.43M |
| May 09, 2024 | 19.60M |
| May 08, 2024 | 19.28M |
| May 07, 2024 | 18.84M |
| May 06, 2024 | 18.64M |
| May 03, 2024 | 18.54M |
| May 02, 2024 | 18.30M |
| May 01, 2024 | 18.05M |
| April 30, 2024 | 15.94M |
| April 29, 2024 | 15.85M |
| April 26, 2024 | 15.40M |
| April 25, 2024 | 15.01M |
| April 24, 2024 | 15.21M |
| April 23, 2024 | 14.82M |
| April 22, 2024 | 15.31M |
| April 19, 2024 | 16.53M |
| April 18, 2024 | 16.88M |
| April 17, 2024 | 16.97M |
| April 16, 2024 | 16.68M |
| April 15, 2024 | 17.32M |
| April 12, 2024 | 17.71M |
| April 11, 2024 | 17.56M |
| Date | Value |
|---|---|
| April 10, 2024 | 17.47M |
| April 09, 2024 | 17.32M |
| April 08, 2024 | 19.48M |
| April 05, 2024 | 19.04M |
| April 04, 2024 | 19.08M |
| April 03, 2024 | 19.08M |
| April 02, 2024 | 19.28M |
| April 01, 2024 | 19.92M |
| March 28, 2024 | 20.07M |
| March 27, 2024 | 21.29M |
| March 26, 2024 | 21.10M |
| March 25, 2024 | 21.51M |
| March 22, 2024 | 21.88M |
| March 21, 2024 | 22.47M |
| March 20, 2024 | 21.54M |
| March 19, 2024 | 20.16M |
| March 18, 2024 | 21.29M |
| March 15, 2024 | 22.57M |
| March 14, 2024 | 22.32M |
| March 13, 2024 | 21.93M |
| March 12, 2024 | 23.89M |
| March 11, 2024 | 25.12M |
| March 08, 2024 | 26.30M |
| March 07, 2024 | 26.79M |
| March 06, 2024 | 27.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.920M
Minimum
Nov 07 2022
468.00M
Maximum
Feb 12 2020
55.64M
Average
20.96M
Median
Jan 25 2023
Market Cap Benchmarks
| Eli Lilly and Co | 731.81B |
| SIGA Technologies Inc | 561.51M |
| Vanda Pharmaceuticals Inc | 325.04M |
| Tenon Medical Inc | 3.280M |
| NovaBay Pharmaceuticals Inc | 4.544M |
Market Cap Related Metrics
| Price to Book Value | 2.240 |
| Price | 4.60 |
| Earnings Yield | -70.00% |